Clinical Trials Browser

Phase 4 × Has results × Dasatinib × Clear all

NCT01660906 2016-11-22

Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib

Phase 4 Completed

39 enrolled 14 charts

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase